Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the risk factors for and frequency of depression during interferon-based treatment for HCV infection
- Discuss management strategies for depression in hepatitis C patients, including pretreatment assessment, prevention, and treatment
- Recount the effects of HCV infection and treatment on cognition, sleep patterns, and mood
- Describe the management of psychiatric disorders in hepatitis C patients with concurrent drug addiction
Topics covered include:
- Clinical Data and Best Practices for Managing Depression in HCV-Infected Patients Treated With Peginterferon and Ribavirin